Vimovo and Miralax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vimovo (esomeprazole magnesium; naproxen) and Miralax (polyethylene glycol 3350). Common drug interactions include human chorionic gonadotropin increased among females and haemolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Vimovo and Miralax. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

On Aug, 12, 2026

36 people who take Vimovo and Miralax together, and have interactions are studied.

What are the common drug interactions of Vimovo and Miralax, by gender? *:

female:

Human chorionic gonadotropin increased
Chronic kidney disease
Renal failure (kidney dysfunction)
Fibromyalgia (a long-term condition which causes pain all over the body)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Anxiety
Balance disorder
Depression
Dry mouth
Fall

male:

Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Oesophageal squamous cell carcinoma (cancer that begins in flat cells lining the oesophagus)
Plasma cell myeloma (cancer that begins in plasma cells)
Pulmonary embolism (blockage of the main artery of the lung)
Renal failure acute (rapid kidney dysfunction)
Syncope (loss of consciousness with an inability to maintain postural tone)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Oesophageal ulcer (ulcer of oesophagus)
Cardiac arrest
Chronic kidney disease

What are the common drug interactions of Vimovo and Miralax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Chronic kidney disease
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Hypertension (high blood pressure)

50-59:

Human chorionic gonadotropin increased
Accident at work
Arthralgia (joint pain)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Impaired work ability
Limb injury
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Pain in jaw
Trigeminal neuralgia (a painful condition of the nerve responsible for most facial sensation)

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Fatigue (feeling of tiredness)
Plasma cell myeloma (cancer that begins in plasma cells)
Pulmonary embolism (blockage of the main artery of the lung)
Renal failure acute (rapid kidney dysfunction)
Syncope (loss of consciousness with an inability to maintain postural tone)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 33.33%
Insomnia (sleeplessness): 11 people, 30.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 13.89%
Pain: 4 people, 11.11%
Blood Pressure Abnormal: 3 people, 8.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 8.33%
Joint Pain: 3 people, 8.33%
Itching: 3 people, 8.33%
Renal Disorder (kidney disease): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vimovo and Miralax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously